Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009

To estimate the incidence of and risk factors for modifications to first antiretroviral therapy (ART) regimen, treatment interruption and death. A total of 21 801 patients from 18 cohorts in Europe and North America starting ART on regimens including at least two nucleoside reverse transcriptase inh...

Full description

Saved in:

Bibliographic Details
Published in:	AIDS (London) Vol. 27; no. 5; p. 803
Main Authors:	Abgrall, Sophie, Ingle, Suzanne M, May, Margaret T, Costagliola, Dominque, Mercie, Patrick, Cavassini, Matthias, Reekie, Joanne, Samji, Hasina, Gill, M John, Crane, Heidi M, Tate, Jan, Sterling, Timothy R, Antinori, Andrea, Reiss, Peter, Saag, Michael S, Mugavero, Michael J, Phillips, Andrew, Manzardo, Christian, Wasmuth, Jan-Christian, Stephan, Christoph, Guest, Jodie L, Gomez Sirvent, Juan Luis, Sterne, Jonathan A C
Format:	Journal Article
Language:	English
Published:	England 13.03.2013
Subjects:	Adenine - administration & dosage Adenine - adverse effects Adenine - analogs & derivatives Alkynes Anti-HIV Agents - administration & dosage Anti-HIV Agents - adverse effects Antiretroviral Therapy, Highly Active - methods Benzoxazines - administration & dosage Benzoxazines - adverse effects Cohort Studies Cyclopropanes Deoxycytidine - administration & dosage Deoxycytidine - adverse effects Deoxycytidine - analogs & derivatives Dideoxynucleosides - administration & dosage Dideoxynucleosides - adverse effects Drug Combinations Emtricitabine Europe - epidemiology HIV Infections - drug therapy HIV Infections - mortality HIV Protease Inhibitors - administration & dosage HIV Protease Inhibitors - adverse effects HIV Seropositivity - drug therapy HIV Seropositivity - mortality HIV-1 Humans Lamivudine - administration & dosage Lamivudine - adverse effects Lopinavir - administration & dosage Lopinavir - adverse effects Nevirapine - administration & dosage Nevirapine - adverse effects Organophosphonates - administration & dosage Organophosphonates - adverse effects Reverse Transcriptase Inhibitors - administration & dosage Reverse Transcriptase Inhibitors - adverse effects Risk Factors Tenofovir Time Factors United States - epidemiology United States Europe
ISSN:	1473-5571, 1473-5571
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!